Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosis

Revista Brasileira de Reumatologia (English Edition) Pub Date : 2017-01-01 DOI:10.1016/j.rbre.2017.07.001

Sebastião Cézar Radominski , Wanderley Bernardo , Ana Patrícia de Paula , Ben-Hur Albergaria , Caio Moreira , Cesar Eduardo Fernandes , Charlles H.M. Castro , Cristiano Augusto de Freitas Zerbini , Diogo S. Domiciano , Laura M.C. Mendonça , Luciano de Melo Pompei , Mailze Campos Bezerra , Marco Antônio R. Loures , Maria Celeste Osório Wender , Marise Lazaretti-Castro , Rosa M.R. Pereira , Sergio Setsuo Maeda , Vera Lúcia Szejnfeld , Victoria Z.C. Borba

{"title":"Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosis","authors":"Sebastião Cézar Radominski , Wanderley Bernardo , Ana Patrícia de Paula , Ben-Hur Albergaria , Caio Moreira , Cesar Eduardo Fernandes , Charlles H.M. Castro , Cristiano Augusto de Freitas Zerbini , Diogo S. Domiciano , Laura M.C. Mendonça , Luciano de Melo Pompei , Mailze Campos Bezerra , Marco Antônio R. Loures , Maria Celeste Osório Wender , Marise Lazaretti-Castro , Rosa M.R. Pereira , Sergio Setsuo Maeda , Vera Lúcia Szejnfeld , Victoria Z.C. Borba","doi":"10.1016/j.rbre.2017.07.001","DOIUrl":null,"url":null,"abstract":"<div><p>Osteoporosis is the leading cause of fractures in the population older than 50 years. This silent disease affects primarily postmenopausal women and the elderly, and the morbidity and mortality rates are high. The main goal of treating osteoporosis is the prevention of fractures. The identification of populations at risk through early diagnosis and treatment is essential. The last Brazilian guideline for the treatment of postmenopausal osteoporosis was elaborated in 2002. Since then, new strategies for diagnosis and risk stratification have been developed, and drugs with novel action mechanisms have been added to the therapeutic arsenal. The Osteoporosis and Osteometabolic Diseases Committee of the Brazilian Society of Rheumatology, in conjunction with the Brazilian Medical Association and other Societies, has developed this update of the guidelines for the treatment of postmenopausal osteoporosis according to the best scientific evidence available. This update is intended for professionals in many medical and health specialties involved in the treatment of osteoporosis, for physicians in general and for health-related organizations.</p></div>","PeriodicalId":101096,"journal":{"name":"Revista Brasileira de Reumatologia (English Edition)","volume":"57 ","pages":"Pages 452-466"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rbre.2017.07.001","citationCount":"43","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Brasileira de Reumatologia (English Edition)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2255502117300470","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 43

Abstract

Osteoporosis is the leading cause of fractures in the population older than 50 years. This silent disease affects primarily postmenopausal women and the elderly, and the morbidity and mortality rates are high. The main goal of treating osteoporosis is the prevention of fractures. The identification of populations at risk through early diagnosis and treatment is essential. The last Brazilian guideline for the treatment of postmenopausal osteoporosis was elaborated in 2002. Since then, new strategies for diagnosis and risk stratification have been developed, and drugs with novel action mechanisms have been added to the therapeutic arsenal. The Osteoporosis and Osteometabolic Diseases Committee of the Brazilian Society of Rheumatology, in conjunction with the Brazilian Medical Association and other Societies, has developed this update of the guidelines for the treatment of postmenopausal osteoporosis according to the best scientific evidence available. This update is intended for professionals in many medical and health specialties involved in the treatment of osteoporosis, for physicians in general and for health-related organizations.

查看原文本刊更多论文

巴西绝经后骨质疏松症的诊断和治疗指南

骨质疏松症是50岁以上人群骨折的主要原因。这种沉默的疾病主要影响绝经后妇女和老年人，发病率和死亡率很高。治疗骨质疏松症的主要目的是预防骨折。通过早期诊断和治疗确定高危人群至关重要。巴西最后一次绝经后骨质疏松症治疗指南是在2002年制定的。从那时起，诊断和风险分层的新策略已经开发出来，具有新作用机制的药物已经添加到治疗武器库中。巴西风湿病学会骨质疏松症和骨代谢疾病委员会与巴西医学协会和其他协会合作，根据现有的最佳科学证据，制定了绝经后骨质疏松症治疗指南的更新。此更新是针对许多涉及骨质疏松症治疗的医学和卫生专业的专业人员，一般医生和与健康相关的组织。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revista Brasileira de Reumatologia (English Edition)

自引率

0.00%

发文量